Our mission is to offer cost-effective technologies that rapidly, accurately and conveniently collect and detect chemical and biological pathogens that threaten human and animal health. We do this to protect and save lives, address unmet medical needs, provide for better prevention and treatment outcomes and reduce the long-term growth of health care costs. Through our core expertise and patented technologies in particulate collection, concentration, preparation and detection of biological samples, Evogen develops best-in-class products that range from stand-alone modules and assay kits to fully integrated units for dedicated disease detection.
Type
Private
HQ
Kansas City, US
Founded
2001
Evogen was founded in 2001 and is headquartered in Kansas City, US

Key People at Evogen

Richard S Jarman

Richard S Jarman

CEO
Sean Roddy

Sean Roddy

CFO
Sean Reineke

Sean Reineke

CEO & President

Evogen Locations

Kansas City, US

Evogen Metrics

Evogen Summary

Founding Date

2001

Total Funding

$4.89 M

Latest funding size

$852 K

Time since last funding

almost 3 years

Investors

Evogen's latest funding round of $852 K was in February 2014. In total, Evogen has raised $4.89 M.

Evogen Company Life